Labcorp (LH) Stock Insights

LH$367.79—
Medical - Diagnostics & ResearchLarge Cap
Compare
Market cap$29.81BEnterprise value—Revenue (TTM)$14.59BMarket positionTop 25%

Score

40
Bearish
Value
36
Quality
47
Growth
38

Insights

  • Revenue by product
  • Revenue by region
Revenue by product
PeriodValue
FY2012Genomic and Esoteric Testing: 2089800000.0, Ontario, Canada: 335000000.0, Routine Testing: 3246600000.0
FY2013Covance Drug Development: 343100000.0, LabCorp Diagnostics: 5465200000.0
FY2014Clinical diagnostics laboratory: 5682200000.0, Other Segments: 329400000.0
FY2015Clinical diagnostics laboratory: 6199300000.0, LabCorp Diagnostics: 6199300000.0
FY2016Clinical diagnostics laboratory: 6593900000.0, Covance Drug Development: 2844100000.0, LabCorp Diagnostics: 6593900000.0
FY2017Covance Drug Development: 6074400000.0, LabCorp Diagnostics: 14341000000.0
FY2018Covance Drug Development: 2189700000.0, LabCorp Diagnostics: 6664300000.0
FY2019Covance Drug Development: 2341800000.0, LabCorp Diagnostics: 6662600000.0
FY2021Covance Drug Development: 5845500000.0, LabCorp Diagnostics: 10363600000.0
FY2022Covance Drug Development: 5710200000.0, LabCorp Diagnostics: 9203500000.0
FY2023Covance Drug Development: 2774200000.0, LabCorp Diagnostics: 9415100000.0
FY2024LabCorp Diagnostics: 10144300000.0
FY2025LabCorp Diagnostics: 10876500000.0
Revenue by region
PeriodValue
FY2012Ontario, Canada: 335000000.0
FY2015CANADA: 290400000.0, SWITZERLAND: 359700000.0
FY2016CANADA: 295800000.0, SWITZERLAND: 450500000.0
FY2017CANADA: 327800000.0, SWITZERLAND: 484400000.0, UNITED KINGDOM: 302000000.0, UNITED STATES: 8234000000.0
FY2020Europe: 1512200000.0, North America: 11525300000.0
FY2021Europe: 2050800000.0, North America: 13093700000.0

Labcorp (LH) Stock Insights

LH price $367.79 —

Ticker
LH
Price
$367.79
Change
—
Market cap
$29.81B
P/E
29.83
Forward P/E
19.16
Dividend yield
0.78%
Beta
0.84
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
40
Value
36
Quality
47
Growth
38

Stocklytics score rationale: value 36, quality 47, growth 38.

AI Score 75. Labcorp Holdings Inc. has a market cap of $29.3 billion and a price of $361.39, with a price-to-earnings ratio of 29.5, indicating a premium valuation

Insights

Revenue by product
PeriodValue
FY2012Genomic and Esoteric Testing: 2089800000.0, Ontario, Canada: 335000000.0, Routine Testing: 3246600000.0
FY2013Covance Drug Development: 343100000.0, LabCorp Diagnostics: 5465200000.0
FY2014Clinical diagnostics laboratory: 5682200000.0, Other Segments: 329400000.0
FY2015Clinical diagnostics laboratory: 6199300000.0, LabCorp Diagnostics: 6199300000.0
FY2016Clinical diagnostics laboratory: 6593900000.0, Covance Drug Development: 2844100000.0, LabCorp Diagnostics: 6593900000.0
FY2017Covance Drug Development: 6074400000.0, LabCorp Diagnostics: 14341000000.0
FY2018Covance Drug Development: 2189700000.0, LabCorp Diagnostics: 6664300000.0
FY2019Covance Drug Development: 2341800000.0, LabCorp Diagnostics: 6662600000.0
FY2021Covance Drug Development: 5845500000.0, LabCorp Diagnostics: 10363600000.0
FY2022Covance Drug Development: 5710200000.0, LabCorp Diagnostics: 9203500000.0
FY2023Covance Drug Development: 2774200000.0, LabCorp Diagnostics: 9415100000.0
FY2024LabCorp Diagnostics: 10144300000.0
FY2025LabCorp Diagnostics: 10876500000.0
Revenue by region
PeriodValue
FY2012Ontario, Canada: 335000000.0
FY2015CANADA: 290400000.0, SWITZERLAND: 359700000.0
FY2016CANADA: 295800000.0, SWITZERLAND: 450500000.0
FY2017CANADA: 327800000.0, SWITZERLAND: 484400000.0, UNITED KINGDOM: 302000000.0, UNITED STATES: 8234000000.0
FY2020Europe: 1512200000.0, North America: 11525300000.0
FY2021Europe: 2050800000.0, North America: 13093700000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener